Translating From Egg- to Antigen-Based Indicators for
EPHP
G-Score
NTDs
POC-CCA
diagnostics
gold standard
intestinal schistosomiasis
neglected tropical diseases
Journal
Frontiers in tropical diseases
ISSN: 2673-7515
Titre abrégé: Front Trop Dis
Pays: Switzerland
ID NLM: 101779328
Informations de publication
Date de publication:
18 Feb 2022
18 Feb 2022
Historique:
entrez:
5
7
2022
pubmed:
6
7
2022
medline:
6
7
2022
Statut:
epublish
Résumé
Schistosomiasis is a parasitic disease affecting over 240-million people. World Health Organization (WHO) targets for Schistosoma mansoni elimination are based on Kato-Katz egg counts, without translation to the widely used, urine-based, point-of-care circulating cathodic antigen diagnostic (POC-CCA). We aimed to standardize POC-CCA score interpretation and translate them to Kato-Katz-based standards, broadening diagnostic utility in progress towards elimination. A Bayesian latent-class model was fit to data from 210 school-aged-children over four timepoints pre- to six-months-post-treatment. We used 1) Kato-Katz and established POC-CCA scoring (Negative, Trace, +, ++ and +++), and 2) Kato-Katz and G-Scores (a new, alternative POC-CCA scoring (G1 to G10)). We established the functional relationship between Kato-Katz counts and POC-CCA scores, and the score-associated probability of true infection. This was combined with measures of sensitivity, specificity, and the area under the curve to determine the optimal POC-CCA scoring system and positivity threshold. A simulation parametrized with model estimates established antigen-based elimination targets. True infection was associated with POC-CCA scores of ≥ + or ≥G3. POC-CCA scores cannot predict Kato-Katz counts because low infection intensities saturate the POC-CCA cassettes. Post-treatment POC-CCA sensitivity/specificity fluctuations indicate a changing relationship between egg excretion and antigen levels (living worms). Elimination targets can be identified by the POC-CCA score distribution in a population. A population with ≤2% ++/+++, or ≤0.5% G7 and above, indicates achieving current WHO Kato-Katz-based elimination targets. Population-level POC-CCA scores can be used to access WHO elimination targets prior to treatment. Caution should be exercised on an individual level and following treatment, as POC-CCAs lack resolution to discern between WHO Kato-Katz-based moderate- and high-intensity-infection categories, with limited use in certain settings and evaluations.
Identifiants
pubmed: 35784267
doi: 10.3389/fitd.2022.825721
pmc: PMC7612949
mid: EMS146323
doi:
Types de publication
Journal Article
Langues
eng
Pagination
825721Subventions
Organisme : Wellcome Trust
ID : 204820
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P025447/1
Pays : United Kingdom
Déclaration de conflit d'intérêts
Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Microbiol Infect. 2015 Jun;21(6):529-42
pubmed: 25843503
Front Immunol. 2021 Mar 12;12:635869
pubmed: 33790908
Open Forum Infect Dis. 2021 Apr 15;8(7):ofab179
pubmed: 34307724
Infect Dis Poverty. 2017 Jun 16;6(1):110
pubmed: 28622767
Am J Trop Med Hyg. 1997 Nov;57(5):571-7
pubmed: 9392598
PLoS Negl Trop Dis. 2017 Oct 4;11(10):e0005953
pubmed: 28976979
Acta Trop. 2019 Nov;199:105150
pubmed: 31425672
Clin Infect Dis. 2022 May 3;74(9):1557-1563
pubmed: 34358299
Parasit Vectors. 2010 Feb 05;3(1):7
pubmed: 20181101
Acta Trop. 2021 May;217:105863
pubmed: 33587944
Acta Trop. 2000 Oct 23;77(1):69-80
pubmed: 10996122
Lancet. 2014 Jun 28;383(9936):2253-64
pubmed: 24698483
Parasit Vectors. 2018 Feb 23;11(1):111
pubmed: 29475457
Bioinformatics. 2005 Oct 15;21(20):3940-1
pubmed: 16096348
Nat Rev Microbiol. 2004 Jan;2(1):12-3
pubmed: 15035004
Parasit Vectors. 2018 Jan 8;11(1):21
pubmed: 29310695
Parasit Vectors. 2019 Sep 16;12(1):437
pubmed: 31522690
PLoS Negl Trop Dis. 2018 Dec 14;12(12):e0006941
pubmed: 30550594
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009200
pubmed: 33657133
PLoS Negl Trop Dis. 2017 Dec 8;11(12):e0006102
pubmed: 29220354
PLoS Negl Trop Dis. 2014 Sep 11;8(9):e3139
pubmed: 25211217
Am J Trop Med Hyg. 2021 Feb 01;104(4):1412-1417
pubmed: 33534739
Bull World Health Organ. 2016 Jul 1;94(7):522-533A
pubmed: 27429491
Antimicrob Agents Chemother. 2000 Oct;44(10):2903-4
pubmed: 10991886
Clin Infect Dis. 2021 Jun 14;72(Suppl 3):S140-S145
pubmed: 33909064
PLoS Negl Trop Dis. 2018 Mar 8;12(3):e0006274
pubmed: 29518081